290 likes | 469 Views
The Common Cold. Causative OrganismsRhinoviruses Coronavirusesviruses also responsible for more severe illnessesadenoviruses, coxsackieviruses, echoviruses, influenza
E N D
1. Respiratory and GI Tract Infections Mark Pallen
2. The Common Cold Causative Organisms
Rhinoviruses
Coronaviruses
viruses also responsible for more severe illnesses
adenoviruses, coxsackieviruses, echoviruses, influenza & parainfluenza viruses, RSV, enteroviruses
Many cases unknown cause Clinical features
rhinorrhoea, sore throat, sneezing, cough
management
Self-limiting
Avoid aspirin in children (risk of Reye’s syndrome)
Avoid antibiotics
3. Sore Throat Clinical features: pharyngitis ± tonsillitis
Causative organisms
mostly viral
bacterial causes:
Streptococcus pyogenes
(a.k.a. Group A beta-haemolytic streptococci)
Less commonly: Corynebacterium diphtheriae, Group C and G beta-haemolytic streptococci, Arcanobacterium haemolyticum, Fusobacterium necrophorum
4. Streptococcal pharyngitis Diagnosis: Throat swab
Plate out on Blood agar
Beta-haemolysis (complete haemolysis)
Lancefield grouping of capsular antigen
Rapid diagnostic tests with fluorescent antibody or latex agglutination
5. Streptococcal pharyngitis Management
Oral Penicillin V for 10 days (to prevent Rheumatic Fever)
Can cause serious wound infections, so...
Isolate patients in hospital
Health workers should stay off work, and MUST STAY OUT of the operating theatre!
6. Streptococcal pharyngitis Complications
Paratonsillar abscess (quinsy)
Scarlet Fever
fine, red, raised rash on trunk & extremities, feels like coarse sandpaper
Sequelae
Rheumatic Fever or Glomerulonephritis
diagnosis: anti-streptolysin O (ASO) antibody titres
7. Diphtheria Acute toxin-mediated disease caused by Corynebacterium diphtheriae
Gram-positive aerobic bacillus
Incubation period 2-5 days
Typically involves pharynx and tonsils
leathery adherent membrane, which can cause respiratory obstruction
Toxin effects
Myocarditis
Neuropathy
8. DiphtheriaManagement Diphtheria is a medical emergency!
Urgent need for antiserum ± tracheostomy
Seek expert advice immediately you suspect it!
Do NOT WAIT for bacteriological confirmation
Antibiotic treatment
Erythromycin
Diphtheria is a public health emergency!
Contact Public Health authorities immediately you suspect it!
Notifiable disease
Need for contact tracing, prophylaxis
Prevention: routine childhood vaccination (+ adult boosters?)
9. Glandular Fever a.k.a. “infectious mononucleosis”
Caused by Epstein-Bar virus
Spread by kissing
(incubtaion period ~ 1 month)
Clinical features
Fever, malaise, sore throat, cervical lymphadenopathy
Rarely, splenomegaly, splenic rupture, haemolytic uraemia
Ampicillin and amoxycillin rash
Diagnosis: Serology
Traditionally, detection of heterophil antibodies (agglutinate sheep erythrocytes): Paul Bunnell or monospot tests
More specific anti-EBV antibodies can now be detected
10. Otitis Media & Sinusitis Local spread of organisms from URT , e.g.
Streptococcus pneumoniae
Haemophilus influenzae
viruses probably commonly involved
Clinical features
Fever, local pain, dizziness, deafness
Treatment
Short course of co-amoxiclav
Surgery, e.g. insert grommets
11. Acute Epiglottitis Infective emergency
Caused by Haemophilus influenzae capsular type B (Hib)
Now very rare due to Hib vaccine program
Can lead to acute respiratory obstruction
Patients must be intubated (± tracheostomy)
DO NOT attempt to take throat swabs
DO NOT attempt to have a “look/see” Diagnosis
take blood cultures
H. influenzae requires rich medium
(e.g. lysed blood or chocolate agar)
Requires X and V growth factors on nutrient agar
Management
Intravenous cefotaxime or ceftriaxone
Isolate the patient
Prevention
Hib vaccine
12. Croup & Bronchiolitis RSV & flu/paraflu viruses
Clinical Features:
cold-like symptoms progress to harsh barking cough, worse at night, or when agitated
wheeze in bronchiolitis
can progress to respiratory obstruction or exhaustion, requiring hospitalisation
Diagnosis
Immunofluoresence or PCR on nasopharyngeal aspirate Management
Supportive, e.g. intubation, oxygen, assisted ventilation
in severe or high-risk cases, nebulised ribavirin (for RSV)
Epidemiology
Annual epidemics of RSV in winter months
13. Pertussis“whooping cough” Caused by Bordetella pertussis
a fastidious Gram-negative rod
Clinical Features
Catarrhal stage for ~2 weeks
Paroxysmal stage for 2-6 weeks or longer
Convalescent stage
Sequelae
weight loss, surgical emphysema, brain damage Diagnosis
Lymphocytosis
Culture of B. pertussis from pernasal swab
Management
erythromycin in catarrhal stage
TOO LATE in paroxysmal stage!
BUT still prevents infectivity
Supportive treatment for paroxysms
Prevention
Vaccination as part of DTP x3
14. Acute LRTI Various clinical syndromes
Bronchopneumonia
Diffuse patchy consolidation
S. pneumoniae, H. influenzae
Lobar pneumonia
Typically S. pneumoniae
Interstitial pneumonia
Characteristically viral
Lung abscess
Atypical pneumonia
15. Pneumococcal pneumonia Diagnosis
Blood cultures ± sputum
Strept. pneumoniae
a.k. a. the pneumococcus
Seen on Gram stain
Grows on blood agar
Draughtman’s colonies
Bile soluble
Optochin-sensitive Treatment
Traditionally benzylpenicillin
Risk of resistance means blind therapy with cefotaxime or ceftriaxone
Prevention
Polyvalent pneumococcal vaccine
Offered to those at risk
Elderly (>65)
splenectomised patients
Diabetics, alcoholics, CSF leak, COAD
16. Atypical Pneumonia Caused by
Mycoplasma pneumoniae (unusual bacterium)
Legionella pneumophila (fastidious GNR)
Chlamydia psittaci, C. pneumoniae
Empirical treatment of all community-acquired pneumonia should include erythromycin to cover “atypicals”
Diagnosis
antigen detection & culture for L. pneumophila
Serology ± PCR for all “atypicals”
17. Influenza Epidemiology
Yearly epidemics in winter months
antigenic drift: point-mutational changes
Intermittent worldwide pandemics with increased morbidity and mortality
antigenic shift: recombination in birds, pigs
totally new antigen types
Rates of infection highest among children
Severity increased greatly among elderly, those with medical conditions
18. Influenza Two types (A and B) and many subtypes
Type and subtype related to surface antigens (hemagglutinin and neuraminidase)
Immunity decreases likelihood and severity of disease
Immunity to one type or subtype offers little to no immunity to others
19. Influenza Clinical features
Abrupt onset fever, myalgias, headache, malaise, sore throat, rhinitis, nonproductive cough
Complications
viral pneumonia and/or bacterial superinfection
typically S. pneumoniae
Hospitalisation and Death
greatest among elderly Antiviral agents
shorten or prevent disease
traditional
amantadine (A)
neuraminidase inhibitors
oseltamivir (A and B) and zanamivir (A and B)
Influenza vaccination
> 65 years old
Others at risk of complications
Health care staff?
20. Tuberculosisnatural history & clinical features Caused by Mycobacterium tuberculosis
Primary infection
asymptomatic or non-specific symptoms: fever, malaise, weight loss, night sweats
Inhalation of tubercle bacilli
leads to lung infection
Ingestion of tubercle bacilli
tonsils & cervical nodes
small bowel with mesenteric nodes
Direct implantation into skin
21. Progressive Primary Infection local erosion by primary focus
pleural cavity = pleurisy
pericardium = pericarditis
bronchus = tuberculous bronchopneumonia (highly infectious) disseminated infection
miliary tuberculosis
multiple discrete granulomas resembling millet seeds
metastatic infection
tuberculous meningitis
bone & joint
kidney
uterus/testis
22. Post-Primary Infection as a result of reactivation of latent infection
latent period between primary infection and reactivation can be several decades
certain factors predispose to reactivation:
immunosuppression, e.g. AIDS, cytotoxics
malnutrition
alcoholism
diabetes
old age
23. Diagnosis Clinical features
Constitutional
Fever, Malaise, Weight loss, Night sweats
Focal
Cough, Haemoptysis, Chest pain
Radiological features
Patchy opacities mainly in the upper zone
cavitation, calcification, hilar shadowing
diffuse nodular shadowing in miliary TB
24. Lab Diagnosis Specimens large multiple specimens in sterile containers
pulmonary TB
early morning sputum specimens (x3)
gastric washings
bronchoscopy specimens
a single negative sample does not rule out tuberculosis extra-pulmonary TB
EMUs, LNs, BM, CSF
unfixed!
special risk to lab staff
Category 3 pathogens
In sealed leak-proof container
Danger of Infection label
In plastic bag
25. Diagnosis Microscopy stain poorly with the Gram-stain
Acid-fast bacilli (AFBs) rely on Acid-fast staining
Ziehl-Neelsen stain
26. Diagnosis Culture Lowenstein-jensen slopes
M. tuberculosis grows after 4-6 weeks, rough buff an tough, breadcrumb-like colonies
Kirschner’s broth
27. Tuberculin Testing Mantoux test, Heaf test
Purified protein derivative (PPD)
delayed type (Type IV) hypersensitivity
Positive
Induration not erythema
past or present infection
or previous BCG vaccination
Negative
no previous infection or vaccination
28. TuberculosisTreatment Multi-drug regimens used
prevent the emergence of resistance during therapy & more effective
Initial Phase: 3 drugs for 2 months
Continuation Phase: 2 drugs for 4-7 months
Seek expert advice from chest physician!
compliance problems & drug toxicity common
repeated consultations
risk of resistance
29. Prevention of tuberculosis Eradicate poverty
Control TB in cattle
Early diagnosis & treatment of cases
Side-room isolation of open “smear-positive” cases in hospital
Selective screening with CXR
Follow up of contacts of cases
TUBERCULOSIS IS A NOTIFIABLE DISEASE
Notification of the Public Health authorities is a legal requirement!!
Immunisation with BCG
traditionally at 11-13 years
at birth in at risk infants
30. Two new interlocking problems Effect of HIV pandemic on TB
Greatest public health disaster since the bubonic plague...
Evil synergy between TB and HIV infection
Reactivation rates much higher in HIV-positives
10% lifetime risk of reactivation in HIV-negatives
8% annual risk in HIV-positives
TB more aggressive in HIV-positives Emergence of multi-resistant TB
In many areas, eg NYC, Nepal, Florida, multi-resistant strains have emerged, resistant to most, if not all, anti-TB drugs
several outbreaks of multi-resistant TB in the USA, often centred on HIV-positive patients
Medical & prison staff have caught fatal untreatable tuberculosis!